FDA MedWatch - Medtronic Expands Recall of Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks - Healthy Food Deals

If your email program has trouble displaying this email, view as a webpage. MedWatch - The FDA Safety Information and Adverse Event Reporting Program Medtronic Expands Recall of Remote Controllers Used with Paradigm and 508 MiniMed Insulin Pumps for Potential Cybersecurity Risks Today, Medtronic expanded its 2018 recall of remote controllers used with either the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps due to potential cybersecurity risks. Medtronic updated recommendations for people who may still be using the remote controllers, including instructions to stop using and return the remote controller. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Questions?  If you have questions about this recall, contact Medtronic's 24-Hour Technical Support line at 1-800-378-2292 and visit medtronicdiabetes.com/RemoteControl.  Read More

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA